322 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

600080

Ginwa Enterprise (Group)
CN¥7.122.4%-6.6%CN¥2.7bn/aPS4.6xn/a0%

504

Landfar Bio-medicine
CN¥7.8915.4%-34.1%CN¥2.6bn/aPS20.3xn/an/a

2898

Sailong Pharmaceutical GroupLtd
CN¥10.124.5%-9.4%CN¥1.8bn/aPE186.8xn/a0%

813

Dezhan Healthcare
CN¥2.827.2%-15.1%CN¥6.1bn/aPE94.4xn/a0%

2793

Luoxin Pharmaceuticals Group Stock
CN¥4.636.7%-34.8%CN¥5.0bn/aPS2.1xn/a0%

600381

Qinghai Spring Medicinal Resources Technology
CN¥4.546.6%-50.5%CN¥2.7bn/aPS11xn/an/a

603222

Chimin Health Management
CN¥6.187.5%-49.3%CN¥3.3bn/aPS3.6xn/a0.3%

603168

Zhejiang Shapuaisi PharmaceuticalLtd
CN¥8.874.0%-5.1%CN¥3.4bn/aPE468.5xn/a0.4%

688166

BrightGene Bio-Medical Technology
CN¥30.998.7%30.7%CN¥13.1bn/aPE65.3xn/a0.4%

300485

Beijing Science Sun Pharmaceutical
CN¥7.65-1.4%-31.3%CN¥3.7bn/aPS8.1xn/a0.3%

300683

Wuhan Hiteck Biological PharmaLtd
CN¥25.016.6%-29.7%CN¥3.3bn/aPS5.5xn/a0%

300434

Sichuan Goldstone Asia Pharmaceutical
CN¥9.035.1%-40.6%CN¥3.6bn/aPE50xn/a0%

300158

Shanxi Zhendong PharmaceuticalLtd
CN¥4.704.4%-24.2%CN¥4.8bn/aPS1.4xn/a0%

688321

Shenzhen Chipscreen Biosciences
CN¥21.91-0.5%-13.2%CN¥8.9bCN¥26.33PE86.7xE-16.0%n/a

2433

Guangdong Taiantang Pharmaceutical
CN¥0.51-10.5%-80.9%CN¥391.1mn/aPS1.2xn/a0%

2435

Changjiang Runfa Health Industry
CN¥2.844.0%-43.2%CN¥3.5bn/aPS1.2xn/a0%

2370

Zhejiang Yatai Pharmaceutical
CN¥3.283.1%-26.0%CN¥2.0bn/aPS4.9xn/a0%

603139

Shaanxi Kanghui Pharmaceutical
CN¥13.944.0%-15.7%CN¥1.4bn/aPS2.1xn/a0%

603716

Thalys Medical Technology Group
CN¥7.246.0%-25.8%CN¥1.4bn/aPB1.2xn/a0%

2755

Beijing Aosaikang Pharmaceutical
CN¥11.1814.5%-0.9%CN¥10.4bn/aPS6.7xn/a0%

2022

Shanghai Kehua Bio-EngineeringLtd
CN¥7.364.8%-41.2%CN¥3.8bn/aPS1.9xn/a0%

300497

Jiangxi Fushine Pharmaceutical
CN¥11.3025.3%-10.2%CN¥6.1bn/aPS3.9xn/a0%

2030

Daan Gene
CN¥6.99-5.7%-50.1%CN¥9.8bn/aPS9.4xn/a0.2%

688197

Shouyao Holdings (Beijing)
CN¥51.52-1.1%-14.3%CN¥7.7bn/aPS1465.3xn/an/a
Page 12 of 14
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.